File:BNT162b2 vaccine efficacy data.png
Jump to navigation
Jump to search
Size of this preview: 781 × 600 pixels. Other resolutions: 313 × 240 pixels | 625 × 480 pixels | 1,000 × 768 pixels | 1,120 × 860 pixels.
Original file (1,120 × 860 pixels, file size: 127 KB, MIME type: image/png)
Captions
Captions
Cumulative incidence curves for symptomatic COVID-19 infections after the first dose of Tozinameran (BNT162b2) or placebo in double-blind clinical trial. (red: placebo; blue: BNT162b2)
Summary[edit]
| Description |
English: Cumulative incidence curves for the first COVID-19 occurrence after first dose of Tozinameran (BNT162b2) or placebo (all-available efficacy population) in double-blind clinical trial submitted to the U.S. FDA for EUA by Pfizer-BioNTech. (red: placebo; blue: BNT162b2) |
| Date | |
| Source | https://www.fda.gov/media/144245/download (p30) |
| Author | U.S Food and Drug Administration and Pfizer Inc. |
Licensing[edit]
|
This chart is ineligible for copyright and therefore in the public domain, because it consists entirely of information that is common property and contains no original authorship. For more information, see Commons:Threshold of originality § Charts
|
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 08:08, 1 January 2021 | | 1,120 × 860 (127 KB) | Wikmoz (talk | contribs) | Uploaded a work by U.S Food and Drug Administration and Pfizer Inc. from https://www.fda.gov/media/144245/download (p30) with UploadWizard |
You cannot overwrite this file.
File usage on Commons
There are no pages that use this file.
File usage on other wikis
The following other wikis use this file:
- Usage on cs.wikipedia.org
- Usage on de.wikipedia.org
- Usage on el.wikipedia.org
- Usage on en.wikipedia.org
- Usage on ja.wikipedia.org
- Usage on sl.wikipedia.org
- Usage on th.wikipedia.org
- Usage on vi.wikipedia.org
